Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation
Journal of Clinical Oncology - United States
doi 10.1200/jco.2012.42.0984
Full Text
Open PDFAbstract
Available in full text
Date
September 10, 2012
Authors
Publisher
American Society of Clinical Oncology (ASCO)